Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
09:36
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2012 World Congress

 

8-12 July, 2012 Paris, FRANCE
Sponsored by:

FAQs
   
Discussion forum - WFH 2012 World Congress
    Topic - Inhibitors Pathogenesis, Prevention and Treatment

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 134
Visits: 534
Title: F8 genotype and not polymorphisms in IL10, TNFA and CTLA4 influences inhibitor development in Argentine patients with severe HA.
Authors: Liliana Rossetti , Claudia Radic, Johanna Zuccoli, Irupé Szurkalo, Martín Abelleyro, Lilian Franzi, Laura Primiani, Miguel Candela, Raúl Pérez Bianco, Miguel de Tezanos Pinto, Irene Larripa, Carlos De Brasi.
Centre: IMEX (CONICET-ANM). IHEMA (Academia Nacional de Medicina). Fundación de la Hemofilia.

You must be registered to reply or comment.

F820GENOTYPE20AND20NOT20POLYMORPHISMS20IN20IL10,20TNFA20AND20CTLA420INFLUENCES20INHIBITOR20DEVELOPMENT20IN20ARGENTINE20PATIENTS20WITH20SEVERE20HA.

Liliana Rossetti
Thread initiator
Subspeciality
Reg: 6/25/2012 5:15:00 PM

Comment# 1

Development of FVIII inhibitors (INH) is a severe treatment complication that affects 20 of patients with severe haemophilia A (HA). Both genetic and environmental factors have been implicated in inhibitor formation. The objective was to characterize genetic factors associated with inhibitors in Argentine patients with severe HA.We characterized the HA-causative mutation in 170 patients classified by INH status by application of a laboratory algorithm including inverse shifting-PCR for F8 inversions, 37 PCR-amplifications for gross deletion detection, and for small-mutation screening by CSGE, and DNA-sequencing. To explore other genetic factors, we studied DNA polymorphisms in the genes encoding for interleukin-10 (IL10) (-1082:A/G), tumour necrosis factor-alpha (TNFA) (-308:G/A), and cytotoxic T-lymphocyte antigen-4 (CTLA4) (-318:C/T) that have been implicated as inhibitor risk factors in other populations.An unbiased series of 119 Argentine patients with severe HA with an absolut

Comment added on 6/25/2012 5:15:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 243
Visits: 2713
Title: Use of the Exergaming (Nintendo Wii) in the Rehabilitation of Patients withHemophilia.
Authors: JANAINA BOSSO JOSÉ DA SILVA , Rafael Fagnani, Egritti de Oliveira Zacarias da Silva,Marcia Aparecida Picoloto Matta, Margareth Castro Ozelo
Centre: UNICAMP

Poster most viewed in this topic
Poster: 133
Visits: 882
Title: A Canadian survey on the incidence and risk factors for inhibitor development insevere hemophilia A PUPs: 2005-2010.
Authors: Georges-Etienne Rivard , M. Carcao, C. Infante-Rivard, A.M. StainE. Paradis, J. Teitel
Centre: CHU Sainte-Justine, Montréal, QC, Canada


 
Sponsored by:















PosterSessionOnline
Logo Draft
 
Logo Cert